Improved yields of full-length functional human FGF1 can be achieved using the methylotrophic yeast Pichia pastoris

Protein Expression and Purification

Volumn 52, Issue 1, 2007, Pages 31-39

  Fantoni, Adele ^a   Bill, Roslyn M ^b   Gustafsson, Lena ^c   Hedfalk, Kristina ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ASTON UNIVERSITY   (United Kingdom)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Human fibroblast growth factor; Overproduction; Pichia pastoris; Purification

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 1; PRIMER DNA; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PICHIA;

3T3 CELLS; ANIMALS; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; FIBROBLAST GROWTH FACTOR 1; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MICE; PICHIA; RECOMBINANT PROTEINS;

PICHIA PASTORIS;

EID: 33845962009     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.10.014     Document Type: Article

References (26)

1. Ornitz D.M., and Itoh N. Fibroblast growth factors. Genome Biol. 2 3 (2001) 1-12
2. Friesel R., and Maciag T. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 82 2 (1999) 748-754
3. Brewer G.J. Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer. Curr. Cancer Drug Targets 5 3 (2005) 195-202
4. Prudovsky I., et al. The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell Sci. 116 Pt. 24 (2003) 4871-4881
5. Sun L., et al. Transfection with aFGF cDNA improves wound healing. J. Invest. Dermatol. 108 3 (1997) 313-318
6. Lopez J.J., et al. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am. J. Physiol. 274 3 Pt. 2 (1998) H930-H936
7. Ware J.A., and Simons M. Angiogenesis in ischemic heart disease. Nat. Med. 3 2 (1997) 158-164
8. Zazo M., et al. High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions. Gene 113 2 (1992) 231-238
9. Wu X., et al. High-level expression and purification of a nonmitogenic form of human acidic fibroblast growth factor in Escherichia coli. Protein Expr. Purif. 42 1 (2005) 7-11
10. Barr P.J., et al. Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 263 31 (1988) 16471-16478
11. Wu X., et al. High-level expression of human acidic fibroblast growth factor and basic fibroblast growth factor in silkworm (Bombyx mori L.) using recombinant baculovirus. Protein Expr. Purif. 21 1 (2001) 192-200
12. Higgins D.R., and Cregg J.M. Introduction to Pichia pastoris. Methods Mol. Biol. 103 (1998) 1-15
13. Cereghino G.P., et al. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr. Opin. Biotechnol. 13 4 (2002) 329-332
14. Macauley-Patrick S., et al. Heterologous protein production using the Pichia pastoris expression system. Yeast 22 4 (2005) 249-270
15. Werten M.W., et al. Secreted production of a custom-designed, highly hydrophilic gelatin in Pichia pastoris. Protein Eng. 14 6 (2001) 447-454
16. Stratton J., Chiruvolu V., and Meagher M. High cell-density fermentation. Methods Mol. Biol. 103 (1998) 107-120
17. Bushell M.E., et al. Cyclic fed-batch culture for production of human serum albumin in Pichia pastoris. Biotechnol. Bioeng. 82 6 (2003) 678-683
18. Cereghino J.L., and Cregg J.M. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 24 1 (2000) 45-66
19. Boysen S., et al. Recombinant human serum amyloid P component from Pichia pastoris: production and characterization. Protein Expr. Purif. 35 2 (2004) 284-292
20. Bos I.G., et al. Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor. Biochim. Biophys. Acta 1648 1-2 (2003) 75-83
21. Vo N.V., Tuler J.R., and Lai M.M. Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis. Biochemistry 43 32 (2004) 10579-10591
22. Hayashi Y., et al. Identification and recombinant production of human laminin alpha4 subunit splice variants. Biochem. Biophys. Res. Commun. 299 3 (2002) 498-504
23. Romero A., Pineda-Lucena A., and Gimenez-Gallego G. X-ray structure of native full-length human fibroblast-growth factor at 0.25-nm resolution. Eur. J. Biochem. 241 2 (1996) 453-461
24. Bernett M.J., Somasundaram T., and Blaber M. An atomic resolution structure for human fibroblast growth factor 1. Proteins 57 3 (2004) 626-634
25. Pineda-Lucena A., et al. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog. J. Mol. Biol. 264 1 (1996) 162-178
26. Lozano R.M., et al. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Biochemistry 39 17 (2000) 4982-4993